Patient Values, Preferences, and Expectations for Managing Symptoms Due to Benign Prostate Obstruction.

IF 4.8 2区 医学 Q1 UROLOGY & NEPHROLOGY
Sachin Malde, Marcus J Drake, Kari A O Tikkinen
{"title":"Patient Values, Preferences, and Expectations for Managing Symptoms Due to Benign Prostate Obstruction.","authors":"Sachin Malde, Marcus J Drake, Kari A O Tikkinen","doi":"10.1016/j.euf.2025.05.018","DOIUrl":null,"url":null,"abstract":"<p><p>An exploration of a patient's values and preferences is an essential component of the shared decision-making (SDM) process. For the management of symptomatic benign prostate enlargement, for which there are numerous treatment options that differ in their risks, benefits, and trade-offs, it is important to empower patients so that they are able to play an active role in decisions on their treatment. The goal is to ensure that choices reflect an individual's needs, desires, and values, thereby promoting satisfaction and minimising later regret. Preferences for the management of male lower urinary tract symptoms vary widely and are shaped by various factors, including age, symptom severity, and level of sexual activity at baseline. Patient decision aids can support SDM by helping patients to choose treatments that align with what matters most to them. To fully integrate SDM into clinical practice, decision aids should be included in clinical guidelines and kept up to date. In this context, patients need clear, honest information about outcomes that matter to them, such as symptom relief, the likelihood of catheterisation, sexual and continence function, and perioperative risks. Ultimately, the success of management should be defined by the patient. PATIENT SUMMARY: Treatment for an enlarged prostate causing urinary symptoms should be personalised. Patients should discuss their individual preferences with their urologist before deciding which treatment is likely to suit them best.</p>","PeriodicalId":12160,"journal":{"name":"European urology focus","volume":" ","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European urology focus","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.euf.2025.05.018","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

An exploration of a patient's values and preferences is an essential component of the shared decision-making (SDM) process. For the management of symptomatic benign prostate enlargement, for which there are numerous treatment options that differ in their risks, benefits, and trade-offs, it is important to empower patients so that they are able to play an active role in decisions on their treatment. The goal is to ensure that choices reflect an individual's needs, desires, and values, thereby promoting satisfaction and minimising later regret. Preferences for the management of male lower urinary tract symptoms vary widely and are shaped by various factors, including age, symptom severity, and level of sexual activity at baseline. Patient decision aids can support SDM by helping patients to choose treatments that align with what matters most to them. To fully integrate SDM into clinical practice, decision aids should be included in clinical guidelines and kept up to date. In this context, patients need clear, honest information about outcomes that matter to them, such as symptom relief, the likelihood of catheterisation, sexual and continence function, and perioperative risks. Ultimately, the success of management should be defined by the patient. PATIENT SUMMARY: Treatment for an enlarged prostate causing urinary symptoms should be personalised. Patients should discuss their individual preferences with their urologist before deciding which treatment is likely to suit them best.

患者对良性前列腺梗阻的价值、偏好和期望。
探索患者的价值观和偏好是共同决策(SDM)过程的重要组成部分。对于有症状的良性前列腺肿大的治疗,有许多治疗方案在其风险、益处和权衡方面有所不同,赋予患者权力使他们能够在治疗决策中发挥积极作用是很重要的。目标是确保选择反映了个人的需求、愿望和价值观,从而提高满意度,并尽量减少后来的遗憾。男性下尿路症状治疗的偏好差异很大,受各种因素影响,包括年龄、症状严重程度和基线时的性活动水平。患者决策辅助工具可以通过帮助患者选择对他们最重要的治疗方法来支持SDM。为了使SDM充分融入临床实践,决策辅助工具应纳入临床指南并保持更新。在这种情况下,患者需要清楚、诚实地了解对他们有影响的结果,如症状缓解、导尿的可能性、性功能和失禁功能以及围手术期风险。最终,管理的成功与否应该由患者来决定。患者总结:前列腺肥大引起的泌尿系统症状的治疗应个体化。在决定哪种治疗方法可能最适合他们之前,患者应该与泌尿科医生讨论他们的个人偏好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
European urology focus
European urology focus Medicine-Urology
CiteScore
10.40
自引率
3.70%
发文量
274
审稿时长
23 days
期刊介绍: European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU). EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信